GB1319315A
(en)
|
1969-06-19 |
1973-06-06 |
Citizen Watch Co Ltd |
Calendar timepiece
|
US3691016A
(en)
|
1970-04-17 |
1972-09-12 |
Monsanto Co |
Process for the preparation of insoluble enzymes
|
US3940475A
(en)
|
1970-06-11 |
1976-02-24 |
Biological Developments, Inc. |
Radioimmune method of assaying quantitatively for a hapten
|
CA1023287A
(en)
|
1972-12-08 |
1977-12-27 |
Boehringer Mannheim G.M.B.H. |
Process for the preparation of carrier-bound proteins
|
US4195128A
(en)
|
1976-05-03 |
1980-03-25 |
Bayer Aktiengesellschaft |
Polymeric carrier bound ligands
|
US4330440A
(en)
|
1977-02-08 |
1982-05-18 |
Development Finance Corporation Of New Zealand |
Activated matrix and method of activation
|
CA1093991A
(en)
|
1977-02-17 |
1981-01-20 |
Hideo Hirohara |
Enzyme immobilization with pullulan gel
|
US4229537A
(en)
|
1978-02-09 |
1980-10-21 |
New York University |
Preparation of trichloro-s-triazine activated supports for coupling ligands
|
US4376110A
(en)
|
1980-08-04 |
1983-03-08 |
Hybritech, Incorporated |
Immunometric assays using monoclonal antibodies
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
DE3422247A1
(de)
|
1984-06-15 |
1985-12-19 |
Pfeifer & Langen, 5000 Köln |
Gluco-oligosaccharid-gemisch und verfahren zu seiner herstellung
|
US4737456A
(en)
|
1985-05-09 |
1988-04-12 |
Syntex (U.S.A.) Inc. |
Reducing interference in ligand-receptor binding assays
|
US5567610A
(en)
|
1986-09-04 |
1996-10-22 |
Bioinvent International Ab |
Method of producing human monoclonal antibodies and kit therefor
|
WO1989004838A1
(en)
|
1987-11-25 |
1989-06-01 |
Immunex Corporation |
Interleukin-1 receptors
|
US5359037A
(en)
|
1988-09-12 |
1994-10-25 |
Yeda Research And Development Co. Ltd. |
Antibodies to TNF binding protein I
|
GB8823869D0
(en)
|
1988-10-12 |
1988-11-16 |
Medical Res Council |
Production of antibodies
|
WO1990005183A1
(en)
|
1988-10-31 |
1990-05-17 |
Immunex Corporation |
Interleukin-4 receptors
|
US4847745A
(en)
|
1988-11-16 |
1989-07-11 |
Sundstrand Corp. |
Three phase inverter power supply with balancing transformer
|
US5175384A
(en)
|
1988-12-05 |
1992-12-29 |
Genpharm International |
Transgenic mice depleted in mature t-cells and methods for making transgenic mice
|
US5011778A
(en)
|
1989-05-23 |
1991-04-30 |
Otsuka Pharmaceutical Co., Ltd. |
Monoclonal antibodies directed to IL-1 activated endothelial cells and medicaments employing the monoclonal antibodies
|
EP0402226A1
(en)
|
1989-06-06 |
1990-12-12 |
Institut National De La Recherche Agronomique |
Transformation vectors for yeast yarrowia
|
DE3920358A1
(de)
|
1989-06-22 |
1991-01-17 |
Behringwerke Ag |
Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
|
DE69026627T2
(de)
|
1989-12-20 |
1996-08-22 |
Schering Corp |
Antikörperantagonisten gegen humanes interleukin-4
|
US5229275A
(en)
|
1990-04-26 |
1993-07-20 |
Akzo N.V. |
In-vitro method for producing antigen-specific human monoclonal antibodies
|
US5571894A
(en)
|
1991-02-05 |
1996-11-05 |
Ciba-Geigy Corporation |
Recombinant antibodies specific for a growth factor receptor
|
CA2083826C
(en)
|
1991-03-29 |
1999-04-27 |
Daniel Caput |
Protein having cytokine type activity, recombinant dna coding for this protein, transformed cells and microorganisms
|
MX9204374A
(es)
|
1991-07-25 |
1993-03-01 |
Idec Pharma Corp |
Anticuerpo recombinante y metodo para su produccion.
|
US5994514A
(en)
|
1991-08-14 |
1999-11-30 |
Genentech, Inc. |
Immunoglobulin variants
|
US6329509B1
(en)
|
1991-08-14 |
2001-12-11 |
Genentech, Inc. |
Anti-IgE antibodies
|
US5965709A
(en)
|
1991-08-14 |
1999-10-12 |
Genentech, Inc. |
IgE antagonists
|
ES2136092T3
(es)
|
1991-09-23 |
1999-11-16 |
Medical Res Council |
Procedimientos para la produccion de anticuerpos humanizados.
|
US5587458A
(en)
|
1991-10-07 |
1996-12-24 |
Aronex Pharmaceuticals, Inc. |
Anti-erbB-2 antibodies, combinations thereof, and therapeutic and diagnostic uses thereof
|
JPH07501451A
(ja)
|
1991-11-25 |
1995-02-16 |
エンゾン・インコーポレイテッド |
多価抗原結合タンパク質
|
WO1993016185A2
(en)
|
1992-02-06 |
1993-08-19 |
Creative Biomolecules, Inc. |
Biosynthetic binding protein for cancer marker
|
WO1993015766A1
(en)
|
1992-02-10 |
1993-08-19 |
Seragen, Inc. |
Desensitization to specific allergens
|
CA2128862C
(en)
|
1992-02-11 |
2008-05-20 |
Jonathan G. Seidman |
Homogenotization of gene-targeting events
|
US5573905A
(en)
|
1992-03-30 |
1996-11-12 |
The Scripps Research Institute |
Encoded combinatorial chemical libraries
|
CA2096289A1
(en)
|
1992-05-15 |
1993-11-16 |
Wouter Musters |
Cloning and expression of dna encoding a ripening form of a polypeptide having rhamnogalacturonase activity
|
US5397703A
(en)
|
1992-07-09 |
1995-03-14 |
Cetus Oncology Corporation |
Method for generation of antibodies to cell surface molecules
|
WO1994004680A1
(en)
|
1992-08-21 |
1994-03-03 |
Schering Corporation |
Human interleukin-13
|
US5596072A
(en)
|
1992-08-21 |
1997-01-21 |
Schering Corporation |
Method of refolding human IL-13
|
JP3095175B2
(ja)
|
1992-11-13 |
2000-10-03 |
アイデック ファーマシューティカルズ コーポレイション |
B細胞リンパ腫の治療のためのヒトbリンパ球限定分化抗原に対するキメラ抗体と放射能標識抗体の療法利用
|
EP0604693A1
(en)
|
1992-12-29 |
1994-07-06 |
Schering-Plough |
Monoclonal antibodies against the human interleukin-4 receptor and hybridomas producing the same
|
ATE175239T1
(de)
|
1993-05-17 |
1999-01-15 |
Genentech Inc |
Sialidase defiziente zellen
|
AU696235B2
(en)
|
1993-09-02 |
1998-09-03 |
Bristol-Myers Squibb Company |
Anti-GP39 antibodies and uses therefor
|
EP0659766A1
(en)
|
1993-11-23 |
1995-06-28 |
Schering-Plough |
Human monoclonal antibodies against human cytokines and methods of making and using such antibodies
|
US5429746A
(en)
|
1994-02-22 |
1995-07-04 |
Smith Kline Beecham Corporation |
Antibody purification
|
US5534615A
(en)
|
1994-04-25 |
1996-07-09 |
Genentech, Inc. |
Cardiac hypertrophy factor and uses therefor
|
GB9415379D0
(en)
|
1994-07-29 |
1994-09-21 |
Smithkline Beecham Plc |
Novel compounds
|
US5705154A
(en)
|
1995-03-08 |
1998-01-06 |
Schering Corporation |
Humanized monoclonal antibodies against human interleukin-4
|
US6037453A
(en)
|
1995-03-15 |
2000-03-14 |
Genentech, Inc. |
Immunoglobulin variants
|
US6518061B1
(en)
|
1995-03-15 |
2003-02-11 |
The United States Of America As Represented By The Department Of Health And Human Services |
IL-13 receptor specific chimeric proteins and uses thereof
|
US5641870A
(en)
|
1995-04-20 |
1997-06-24 |
Genentech, Inc. |
Low pH hydrophobic interaction chromatography for antibody purification
|
US6911530B1
(en)
|
1995-10-23 |
2005-06-28 |
Amrad Operations, Pty., Ltd. |
Haemopoietin receptor and genetic sequences encoding same
|
ATE445011T1
(de)
|
1995-10-23 |
2009-10-15 |
Zenyth Operations Pty Ltd |
Hemopoietin-rezeptor und dafür kodierende genetische sequenzen
|
FR2742156A1
(fr)
|
1995-12-06 |
1997-06-13 |
Sanofi Sa |
Polypeptide recepteur de l'il-13
|
CN1300173C
(zh)
|
1996-02-09 |
2007-02-14 |
艾博特生物技术有限公司 |
结合人TNFα的人抗体
|
US6664227B1
(en)
|
1996-03-01 |
2003-12-16 |
Genetics Institute, Llc |
Treatment of fibrosis by antagonism of IL-13 and IL-13 receptor chains
|
US7078494B1
(en)
|
1996-03-01 |
2006-07-18 |
Genetics Institute, Llc |
Antibodies to human IL-13bc and methods of their use in inhibiting IL-13 binding
|
US5710023A
(en)
|
1996-03-01 |
1998-01-20 |
Genetics Institute, Inc. |
IL-13 cytokine receptor chain
|
WO1997047742A1
(en)
|
1996-06-12 |
1997-12-18 |
Smithkline Beecham Corporation |
Hr-1 receptor
|
WO1998010638A1
(en)
|
1996-09-10 |
1998-03-19 |
Amrad Operations Pty. Ltd. |
Therapeutic molecules
|
DK1864999T3
(da)
|
1996-11-27 |
2009-06-29 |
Genentech Inc |
Affinitetsoprensning af polypeptid på protein A-matrix
|
US6743604B1
(en)
|
1996-12-13 |
2004-06-01 |
Smithkline Beecham Corporation |
Substances and their uses
|
GB9625899D0
(en)
|
1996-12-13 |
1997-01-29 |
Glaxo Group Ltd |
Substances and their uses
|
TR199902191T2
(xx)
|
1997-01-10 |
1999-12-21 |
Biogen, Inc. |
Anti-CD40L bile�ikleri ile lupus nefritis tedavisi
|
JP2002514201A
(ja)
|
1997-01-22 |
2002-05-14 |
ボード オブ リージェンツ,ザ ユニバーシティ オブ テキサス システム |
凝固および腫瘍の処置のための組織因子の方法および組成物
|
US6576232B1
(en)
|
1998-04-03 |
2003-06-10 |
The Penn State Research Foundation |
IL13 mutants
|
US6482403B1
(en)
|
1998-05-29 |
2002-11-19 |
Heska Corporation |
Caniney IL-13 immunoregulatory proteins and uses thereof
|
US6299875B1
(en)
|
1998-06-04 |
2001-10-09 |
Panacea Pharmaceuticals, Llc |
Methods to block IGE binding to cell surface receptors of mast cells
|
GB9820014D0
(en)
|
1998-09-14 |
1998-11-04 |
Cancer Res Campaign Tech |
Receptor antagonists and uses thereof
|
US7083950B2
(en)
|
1998-09-25 |
2006-08-01 |
Regeneron Pharmaceuticals, Inc. |
High affinity fusion proteins and therapeutic and diagnostic methods for use
|
DE19848026A1
(de)
|
1998-10-17 |
2000-04-20 |
Bayer Ag |
Verfahren zur Herstellung von Bis(4-hydroxyaryl)alkanen
|
IL127127A0
(en)
|
1998-11-18 |
1999-09-22 |
Peptor Ltd |
Small functional units of antibody heavy chain variable regions
|
US7553487B2
(en)
|
1998-12-14 |
2009-06-30 |
Genetics Institute, Llc |
Method and compositions for treating asthma
|
DK1141286T3
(da)
|
1998-12-14 |
2007-02-19 |
Genetics Inst Llc |
Kæde af cytokinreceptorer
|
US6468528B1
(en)
|
1999-02-01 |
2002-10-22 |
Amgen Canada Inc. |
Materials and methods to inhibit Hodgkin and Reed Sternberg cell growth
|
AU1599301A
(en)
|
1999-11-11 |
2001-06-06 |
Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The |
Modulating IL-13 activity using mutated IL-13 molecules that are antagonists or agonists of IL-13
|
US20100041039A1
(en)
|
2000-01-15 |
2010-02-18 |
Synageva Biopharma Corp. |
Analysis of nucleic acid obtained from nucleated red blood cells
|
KR100767146B1
(ko)
|
2000-02-24 |
2007-10-15 |
워싱톤 유니버시티 |
Aβ 펩티드를 격리시키는 인간화 항체
|
WO2001064754A1
(fr)
|
2000-03-03 |
2001-09-07 |
Kyowa Hakko Kogyo Co., Ltd. |
Anticorps a recombinaison genique et son fragment
|
CN1323812A
(zh)
|
2000-05-16 |
2001-11-28 |
上海博德基因开发有限公司 |
一种新的多肽——人白细胞介素-13(il-13)受体11和编码这种多肽的多核苷酸
|
EP2027867A1
(en)
|
2000-10-20 |
2009-02-25 |
Genetics Institute, LLC |
Method and composition for inhibition of tumor growth and enhancing an immune response
|
AU2002210918B2
(en)
|
2000-10-20 |
2006-03-16 |
Chugai Seiyaku Kabushiki Kaisha |
Degraded agonist antibody
|
US7919467B2
(en)
|
2000-12-04 |
2011-04-05 |
Immunotope, Inc. |
Cytotoxic T-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer
|
EP1345967B1
(en)
|
2000-12-22 |
2011-08-10 |
Grad, Carole, Legal representative of Kaplan, Howard |
Phage display libraries of human v h fragments
|
CA2452058A1
(en)
|
2001-06-26 |
2003-01-09 |
Imclone Systems Incorporated |
Bispecific antibodies that bind to vegf receptors
|
US20030023555A1
(en)
|
2001-07-26 |
2003-01-30 |
Cashworks, Inc. |
Method and system for providing financial services
|
AU2002338015B8
(en)
|
2001-08-31 |
2008-03-20 |
Kyowa Kirin Co., Ltd. |
Human CDR-grafted antibodies and antibody fragments thereof
|
US6908963B2
(en)
|
2001-10-09 |
2005-06-21 |
Nektar Therapeutics Al, Corporation |
Thioester polymer derivatives and method of modifying the N-terminus of a polypeptide therewith
|
JP2005289809A
(ja)
|
2001-10-24 |
2005-10-20 |
Vlaams Interuniversitair Inst Voor Biotechnologie Vzw (Vib Vzw) |
突然変異重鎖抗体
|
WO2003035847A2
(en)
|
2001-10-26 |
2003-05-01 |
Centocor, Inc. |
Il-13 mutein proteins, antibodies, compositions, methods and uses
|
US20030235555A1
(en)
|
2002-04-05 |
2003-12-25 |
David Shealey |
Asthma-related anti-IL-13 immunoglobulin derived proteins, compositions, methods and uses
|
AU2002363382B2
(en)
|
2001-11-07 |
2007-07-19 |
Cytos Biotechnology Ag |
Antigen arrays presenting IL-5, IL-3 or eotaxin for treatment of allergic eosinophilic diseases
|
WO2003066662A2
(en)
|
2002-02-05 |
2003-08-14 |
Genentech, Inc. |
Protein purification
|
US20040060102A1
(en)
|
2002-04-10 |
2004-04-01 |
Interspiro, Inc. |
Garments for biological, chemical and fire protection
|
EP1501369B1
(en)
|
2002-04-26 |
2015-06-24 |
Genentech, Inc. |
Non-affinity purification of proteins
|
NZ537726A
(en)
|
2002-06-14 |
2008-06-30 |
Brigham & Womens Hospital |
Methods of treating and preventing colitis involving IL-13 and NK-T cells
|
AU2003259358A1
(en)
|
2002-08-30 |
2004-03-19 |
Claire Ashman |
Immunogenic composition comprising an il-13 element and t cell epitopes, and its therapeutic use
|
CA2496948A1
(en)
|
2002-08-30 |
2004-03-11 |
Glaxo Group Limited |
Il-14 vaccine for the treatment of asthma and atopic disorders
|
DE10303664A1
(de)
|
2003-01-23 |
2004-08-12 |
Nemod Immuntherapie Ag |
Erkennungsmoleküle zur Behandlung und Detektion von Tumoren
|
WO2004071408A2
(en)
|
2003-02-10 |
2004-08-26 |
Applied Molecular Evolution, Inc. |
Aβ BINDING MOLECULES
|
US7157276B2
(en)
|
2003-06-20 |
2007-01-02 |
Biogen Idec Inc. |
Use of depth filtration in series with continuous centrifugation to clarify mammalian cell cultures
|
CN1845938B
(zh)
|
2003-06-30 |
2010-05-26 |
杜门蒂斯有限公司 |
多肽
|
GB0407315D0
(en)
|
2003-07-15 |
2004-05-05 |
Cambridge Antibody Tech |
Human antibody molecules
|
KR20130041373A
(ko)
*
|
2003-12-23 |
2013-04-24 |
제넨테크, 인크. |
신규 항-il13 항체 및 그 용도
|
MXPA06007856A
(es)
|
2004-01-07 |
2007-03-23 |
Chiron Corp |
Anticuerpo monoclonal especifico de factor de estimulacion de colonias de macrofagos (m-csf) y usos del mismo.
|
US20080261249A1
(en)
|
2004-01-13 |
2008-10-23 |
Genentech, Inc |
Detecting and Quantifying Host Cell Proteins in Recombinant Protein Products
|
BRPI0509495A2
(pt)
|
2004-02-06 |
2016-10-11 |
Nymox Corp |
anticorpo humanizado
|
SI1720909T1
(sl)
|
2004-02-23 |
2012-01-31 |
Lilly Co Eli |
Anti-abeta protitelo
|
US20070037966A1
(en)
*
|
2004-05-04 |
2007-02-15 |
Novo Nordisk A/S |
Hydrophobic interaction chromatography purification of factor VII polypeptides
|
CA2565414A1
(en)
|
2004-05-04 |
2005-11-24 |
Novo Nordisk Health Care Ag |
O-linked glycoforms of polypeptides and method to manufacture them
|
US7501121B2
(en)
|
2004-06-17 |
2009-03-10 |
Wyeth |
IL-13 binding agents
|
US20070048785A1
(en)
|
2004-06-09 |
2007-03-01 |
Lin Laura L |
Anti-IL-13 antibodies and complexes
|
AR049390A1
(es)
|
2004-06-09 |
2006-07-26 |
Wyeth Corp |
Anticuerpos contra la interleuquina-13 humana y usos de los mismos
|
TWI307630B
(en)
|
2004-07-01 |
2009-03-21 |
Glaxo Group Ltd |
Immunoglobulins
|
EA012162B1
(ru)
|
2004-10-22 |
2009-08-28 |
Эмджен Инк. |
Способ рефолдинга рекомбинантных антител
|
WO2006066308A1
(en)
|
2004-12-24 |
2006-06-29 |
Commonwealth Scientific And Industrial Research Organisation |
Pesticide compositions and methods
|
PL1869065T3
(pl)
|
2005-03-11 |
2020-09-21 |
Wyeth Llc |
Sposób prowadzenia chromatografii podziałowej ze słabym wiązaniem
|
WO2006110277A1
(en)
|
2005-04-11 |
2006-10-19 |
Medarex, Inc. |
Protein purification using hcic amd ion exchange chromatography
|
TW200740839A
(en)
|
2005-06-17 |
2007-11-01 |
Wyeth Corp |
Methods of purifying Fc region containing proteins
|
JP3982545B2
(ja)
|
2005-09-22 |
2007-09-26 |
ダイキン工業株式会社 |
空気調和装置
|
GB2430883B
(en)
*
|
2005-09-30 |
2008-03-19 |
Cambridge Antibody Tech |
Interleukin-13 antibody composition
|
JP5006330B2
(ja)
|
2005-10-21 |
2012-08-22 |
ノバルティス アーゲー |
Il13に対するヒト抗体および治療的使用
|
KR20140087058A
(ko)
|
2005-11-30 |
2014-07-08 |
애브비 인코포레이티드 |
아밀로이드 베타 단백질에 대한 모노클로날 항체 및 이의 용도
|
US7667557B2
(en)
|
2005-12-06 |
2010-02-23 |
Tdk Corporation |
Thin-film bandpass filter using inductor-capacitor resonators
|
SG10201404801YA
(en)
|
2005-12-12 |
2014-09-26 |
Ac Immune Sa |
Monoclonal antibody
|
UY30003A1
(es)
|
2005-12-12 |
2007-08-31 |
Hoffmann La Roche |
Anticuerpos glicosilados en la region variable
|
EA200870130A1
(ru)
|
2005-12-30 |
2009-02-27 |
Мерк Патент Гмбх |
Антитела против ил-6, предотвращающие связывание с gp130 комплекса ил-6 и альфа-рецептора ил-6
|
US7563875B2
(en)
|
2006-03-20 |
2009-07-21 |
The United States of America as represented by the Sercretary of the Army |
Recombinant chimeric human anti-botulinum antibodies
|
NZ610566A
(en)
*
|
2006-04-05 |
2014-09-26 |
Abbvie Biotechnology Ltd |
Antibody purification
|
EP2035455A4
(en)
|
2006-04-21 |
2009-10-14 |
Wyeth Corp |
METHOD OF HIGH-BY-SCREEN SCREENING OF CELL LINES
|
WO2008011348A2
(en)
|
2006-07-14 |
2008-01-24 |
Ac Immune S.A. |
Humanized antibody against amyloid beta
|
CL2007002567A1
(es)
|
2006-09-08 |
2008-02-01 |
Amgen Inc |
Proteinas aisladas de enlace a activina a humana.
|
KR20090068266A
(ko)
|
2006-09-21 |
2009-06-25 |
베레늄 코포레이션 |
포스포리파제, 그를 코딩하는 핵산 그리고 그를 제조 및 이용하는 방법
|
PL2074145T3
(pl)
|
2006-10-02 |
2017-11-30 |
Ac Immune S.A. |
Humanizowane przeciwciało przeciw amyloidowi beta
|
PL2069798T3
(pl)
|
2006-10-04 |
2014-09-30 |
Genentech Inc |
Test ELISA dla VEGF
|
US8383350B1
(en)
|
2006-12-20 |
2013-02-26 |
Merck Sharp & Dohme Corp. |
Assay for detection of IL-10 antibodies
|
AU2008204901A1
(en)
|
2007-01-09 |
2008-07-17 |
Wyeth |
Anti-IL-13 antibody formulations and uses thereof
|
WO2008140455A1
(en)
|
2007-05-15 |
2008-11-20 |
Tanox, Inc. |
Treatment of radiation and chemo-therapy induced fibrosis using novel anti-il 13 monoclonal antibodies
|
JP5436414B2
(ja)
|
2007-06-12 |
2014-03-05 |
エーシー イミューン ソシエテ アノニム |
モノクローナル抗βアミロイド抗体
|
KR101670088B1
(ko)
|
2007-06-12 |
2016-10-28 |
에이씨 이뮨 에스.에이. |
아밀로이드 베타에 대해 인간화된 항체
|
US9433922B2
(en)
|
2007-08-14 |
2016-09-06 |
Emd Millipore Corporation |
Media for membrane ion exchange chromatography based on polymeric primary amines, sorption device containing that media, and chromatography scheme and purification method using the same
|
RU2542967C2
(ru)
|
2007-10-05 |
2015-02-27 |
Дженентек, Инк. |
Применение антитела против амилоида бета при глазных заболеваниях
|
RU2538709C2
(ru)
|
2007-10-05 |
2015-01-10 |
Дженентек, Инк. |
Гуманизированное антитело
|
RU2482876C2
(ru)
|
2007-10-05 |
2013-05-27 |
Дженентек, Инк. |
Применение антитела против амилоида-бета при глазных заболеваниях
|
WO2009058769A1
(en)
*
|
2007-10-30 |
2009-05-07 |
Schering Corporation |
Purification of antibodies containing hydrophobic variants
|
BRPI0906261A2
(pt)
|
2008-03-31 |
2015-07-07 |
Genentech Inc |
"métodos de diagnóstico de um subtipo de asma em uma amostra de paciente, usos de um agente terapêutico e kits de diagnóstico de um subtipo de asma em uma amostra de paciente"
|
US8344115B2
(en)
|
2008-04-21 |
2013-01-01 |
Chan-Sui Pang, legal representative |
Immunoassay for specific determination of S-adenosylmethionine and analogs thereof in biological samples
|
KR20150002874A
(ko)
|
2008-05-05 |
2015-01-07 |
노비뮨 에스 에이 |
항-il-17a/il-17f 교차-반응성 항체 및 그의 사용 방법
|
CA2733223C
(en)
|
2008-08-05 |
2018-02-27 |
Toray Industries, Inc. |
Pharmaceutical composition comprising anti-caprin-1 antibody for treatment and prevention of cancers
|
US8790642B2
(en)
*
|
2008-08-29 |
2014-07-29 |
Genentech, Inc. |
Cross-reactive and bispecific anti-IL-17A/F antibodies
|
GB0818674D0
(en)
|
2008-10-10 |
2008-11-19 |
Univ Bath |
Materials and methods for resolving polyhydric species by electrophoresis
|
RU2520838C2
(ru)
|
2008-10-20 |
2014-06-27 |
Эббви Инк |
Выделение и очистка антител с использованием аффинной хроматографии на основе белка а
|
KR20110071011A
(ko)
|
2008-10-20 |
2011-06-27 |
아보트 러보러터리즈 |
Il-18에 결합하는 항체 및 이의 정제 방법
|
JP2012506384A
(ja)
|
2008-10-20 |
2012-03-15 |
アボット・ラボラトリーズ |
Il−12に結合する抗体およびそれを精製する方法
|
CN104974251A
(zh)
|
2008-10-20 |
2015-10-14 |
Abbvie公司 |
在抗体纯化过程中的病毒灭活
|
CN101979404B
(zh)
|
2008-12-09 |
2015-01-14 |
厦门大学 |
H5亚型禽流感病毒保守中和表位模拟肽及其用途
|
FR2944448B1
(fr)
|
2008-12-23 |
2012-01-13 |
Adocia |
Composition pharmaceutique stable comprenant au moins un anticorps monodonal et au moins un polysacharide amphiphile comprenant des substituants derives d'alcools hydrofobes ou d'amines hydrophobes.
|
WO2011010940A1
(en)
|
2009-07-19 |
2011-01-27 |
Serguei Zavtrak |
Solar electric power generator
|
BR112012002574A2
(pt)
|
2009-08-06 |
2020-11-03 |
Genentech, Inc. |
método para aprimorar a remoção de vírus na purificação de proteínas
|
BR112012004823B1
(pt)
|
2009-09-03 |
2021-11-30 |
Merck Sharp & Dohme Corp |
Anticorpo ou fragmento de ligação de antígeno do mesmo, uso de um anticorpo ou um fragmento de ligação de antígeno do mesmo, e composição farmacêutica
|
UA109884C2
(uk)
|
2009-10-16 |
2015-10-26 |
|
Поліпептид, що має активність ферменту фосфатидилінозитол-специфічної фосфоліпази с, нуклеїнова кислота, що його кодує, та спосіб його виробництва і застосування
|
NZ599100A
(en)
*
|
2009-10-20 |
2014-07-25 |
Abbvie Inc |
Isolation and purification of anti-il-13 antibodies using protein a affinity chromatography
|
US9127071B2
(en)
|
2010-01-29 |
2015-09-08 |
Chugai Seiyaku Kabushiki Kaisha |
Anti-DLL3 antibody
|
BR112012022210B1
(pt)
|
2010-03-04 |
2021-08-17 |
Macrogenics, Inc |
Anticorpo isolado ou seu fragmento imunorreativo, molécula de ácido nucleico, composição farmacêutica, e, uso do anticorpo isolado
|
US8802091B2
(en)
|
2010-03-04 |
2014-08-12 |
Macrogenics, Inc. |
Antibodies reactive with B7-H3 and uses thereof
|
ES2616010T3
(es)
|
2010-05-14 |
2017-06-09 |
The Board Of Trustees Of The Leland Stanford Junior University |
Anticuerpos monoclonales humanizados y quiméricos a CD47
|
NZ702053A
(en)
|
2010-05-17 |
2016-01-29 |
Livtech Inc |
Anti-human trop-2 antibody having antitumor activity in vivo
|
BR112012029904A2
(pt)
|
2010-05-25 |
2017-08-08 |
Genentech Inc |
métodos de purificação de polipeptídeos
|
AU2011276285A1
(en)
|
2010-07-06 |
2013-01-24 |
Aveo Pharmaceuticals, Inc. |
Anti-RON antibodies
|
WO2012016173A2
(en)
|
2010-07-30 |
2012-02-02 |
Ac Immune S.A. |
Safe and functional humanized antibodies
|
CA2811087A1
(en)
|
2010-09-29 |
2012-04-12 |
Genentech, Inc. |
Antibody compositions and methods of use
|
CA2818173C
(en)
*
|
2010-11-30 |
2022-05-03 |
Genentech, Inc. |
Low affinity blood brain barrier receptor antibodies and uses therefor
|
TW201732294A
(zh)
|
2010-12-16 |
2017-09-16 |
建南德克公司 |
關於th2抑制作用之診斷及治療
|
JP6072771B2
(ja)
|
2011-04-20 |
2017-02-01 |
メディミューン,エルエルシー |
B7−h1およびpd−1に結合する抗体およびその他の分子
|
RS63948B1
(sr)
|
2011-10-31 |
2023-02-28 |
Hoffmann La Roche |
Formulacije anti-il13 antitela
|
WO2013066707A1
(en)
*
|
2011-10-31 |
2013-05-10 |
Merck Sharp & Dohme Corp. |
Chromatography process for resolving heterogeneous antibody aggregates
|
AR088920A1
(es)
*
|
2011-11-21 |
2014-07-16 |
Genentech Inc |
Purificacion de anticuerpos anti-c-met
|
EP2791176B1
(en)
|
2011-12-15 |
2018-07-11 |
Prestige Biopharma Pte. Ltd. |
A method of antibody purification
|
WO2013120497A1
(en)
*
|
2012-02-15 |
2013-08-22 |
Curevac Gmbh |
Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein
|
WO2013130905A1
(en)
|
2012-02-29 |
2013-09-06 |
Gilead Biologics, Inc. |
Antibodies to matrix metalloproteinase 9
|
NZ718144A
(en)
*
|
2013-09-13 |
2022-05-27 |
Genentech Inc |
Methods and compositions comprising purified recombinant polypeptides
|
EP4163633A1
(en)
|
2013-09-13 |
2023-04-12 |
F. Hoffmann-La Roche AG |
Compositions and methods for detecting and quantifying host cell protein in cell lines and recombinant polypeptide products
|